FabiFlu

Glenmark Commences 1000 Patients Surveillance Study with COVID-19 for FabiFlu

Glenmark has announced a price reduction of 27 per cent for FabiFlu. The new MRP is Rs 75 per tab from the earlier Rs 103 per tab. The price reduction has been made possible through benefits gained from higher yields and better scale, as both the API and formulations are made at Glenmark's facilities in India, the benefits of which are being passed on to patients in the country.